School of Engineering
Showing 4,701-4,710 of 6,991 Results
-
Thomas Puschmann
Affiliate, Center for Sustainable Development and Global Competitiveness
Visiting Scholar, Civil and Environmental EngineeringBioThomas Puschmann is Founder and Executive Director of the Global Center for Sustainable Digital Finance at Stanford University and the University of Zurich. In addition, he is Founder and Director of one of the first FinTech research labs worldwide, the Swiss FinTech Innovation Lab at the University of Zurich, Professor at the University of the Fraser Valley in Canada, Co-Founder of the Association Swiss FinTech Innovations, Co-Founder of the Swiss Green FinTech Network, Co-Founder of Extreme Tech Challenge Switzerland and Member of the Swiss Innovation Council Innosuisse.
Thomas serves as an advisor for many strategic national and international initiatives and is an advisory board member of various institutions to foster innovation and develop an innovation and start-up ecosystem. Before his current position he was heading one of the first digital financial services research projects at the Universities of St. Gallen and Leipzig and was a visiting scholar at MIT Sloan School of Management and Stanford University. Prior to this, Thomas spent five years in consulting and software development, where he was a member of the executive board at ESPRiT Consulting (now Q_Perior) and The Information Management Group.
Thomas holds a master's degree in information systems engineering and a PhD in business informatics engineering from the University of St. Gallen in Switzerland. -
Lei (Stanley) Qi
Associate Professor of Bioengineering
BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is a principal contributor to the development of CRISPR technologies for genome engineering beyond gene editing. His lab created the first nuclease-deactivated Cas9 (dCas9) for targeted gene regulation in cells. His lab has invented a CRISPR toolbox for engineering the epigenome, including CRISPRi and CRISPRa for targeted gene repression and activation, epigenome editing, LiveFISH for real-time DNA/RNA imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a compact CRISPR system for gene therapy, hyperCas12a for multi-gene engineering, and CRISPR antivirals aimed at treating broad RNA viruses.
Dr. Qi obtained B.S. in Physics and Math from Tsinghua University in 2005, and Ph.D. in Bioengineering from the University of California, Berkeley in 2012. He was a Systems Biology Faculty Fellow at UCSF between 2012-2014, and joined Stanford faculty in 2014. His research focuses on mammalian synthetic biology, epigenetic engineering, immune cell engineering, directed evolution, and novel approaches for gene therapy. -
Gary Qian
Ph.D. Student in Management Science and Engineering, admitted Autumn 2021
BioI am currently a 2nd year PhD student in Management Science and Engineering at Stanford working with Professor Margaret Brandeau. My research focuses on the development of applied mathematical, economic models, and machine learning models to support health policy decisions. My recent work has been focused on HIV prevention and treatment programs, programs to control US opioid epidemic, and policies for minimizing spread of infectious diseases (including COVID-19).
I am passionate about using optimization theory and machine learning to implement scalable solutions in solving complex, real-world problems including but not limited to applications in healthcare.
